FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Video Appears to Show Man Shot By ICE Assault Woman, Instigate Violence, Resist Arrest

Gun rights groups clash after man DHS says was armed fatally shot by CBP in Minneapolis

Anti-ICE Rioters Barricading Entire Blocks in Minneapolis, Police Appear MIA

Rep Maxwell Frost allegedly assaulted at Sundance Film Festival in racially-charged incident

Frey, Klobuchar call for ICE to leave Minneapolis following deadly CBP shooting in city

Noem says Minneapolis suspect committed ‘domestic terrorism,’ accuses Walz, Frey of inciting violence

Trump Resurrects Reagan-Era Pro-Life Policy, Punishes and Defunds Foreign Abortion Operations, Gender Madness

Trump to skip Super Bowl in California, criticizes performers Bad Bunny and Green Day

Alex Pretti, 37, identified as man fatally shot by Border Patrol agent in Minneapolis

Anti-ICE agitator allegedly bites off federal officer’s finger during Minneapolis attack

‘Loyal soldier’: A day on the trail with JD Vance, Trump’s ‘human Swiss Army Knife’

READ IT: Bondi sends letter to Gov Walz warning Minnesota’s immigration policies endanger agents

Ever Wonder Why Even Trump Can’t Get Criminal Dems Arrested? They’re Using the ‘Blue Slip’ Trick to Stay Out of Jail and It Has to End

Trump brags about secret weapon that was key to Maduro capture: ‘The discombobulator’

Trump cites armed suspect, lack of police support following fatal Border Patrol shooting in Minneapolis

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”